Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disarming Lyme disease

F S Kantor1

  • 1Yale University.

Scientific American
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Antibiotics effectively treat infections, and a new vaccine is under development. Future research will focus on managing long-term symptoms in patients with chronic conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands.

The Journal of infectious diseases·2001
Same author

SALP16, a gene induced in Ixodes scapularis salivary glands during tick feeding.

The American journal of tropical medicine and hygiene·2000
Same author

Prevention of Borrelia burgdorferi transmission in guinea pigs by tick immunity.

The American journal of tropical medicine and hygiene·1998
Same author

Granulocytic ehrlichiosis in tick-immune guinea pigs.

Infection and immunity·1998
Same author

Immune evasion by tickborne and host-adapted Borrelia burgdorferi.

The Journal of infectious diseases·1998
Same author

Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice.

Journal of immunology (Baltimore, Md. : 1950)·1996
Same journal

50, 100 & 150 Years: Natural fission reactor uncovered; geometry of soap bubbles.

Scientific American·2026
Same journal

Academic Freedom in Decline: When scientists can't research what they want, innovation suffers.

Scientific American·2026
Same journal

Robots Can Now Fold Your Laundry: Home-helper tasks are becoming easier for robotic assistants.

Scientific American·2026
Same journal

Journey to Titan: Inside NASA's Dragonfly mission to Saturn's largest moon.

Scientific American·2026
Same journal

Getting Pesticides Off Fruits and Veggies: Using more than water to wash produce can clean pesticide residues.

Scientific American·2026
Same journal

How Probability Theory Got Its Start: Disagreement over how to divvy up the pot in an interrupted game of chance led early mathematicians to invent modern risk assessment.

Scientific American·2026
See all related articles

Area of Science:

  • Infectious Diseases
  • Immunology
  • Microbiology

Background:

  • Antibiotics are the primary treatment for bacterial infections, offering curative effects.
  • The development of vaccines represents a significant advancement in preventing infectious diseases.
  • A subset of patients experience persistent, chronic symptoms following initial infection.

Purpose of the Study:

  • To review the current efficacy of antibiotic treatments.
  • To assess the progress and potential of a new vaccine in clinical trials.
  • To identify and outline future research directions for managing chronic sequelae of infections.

Main Methods:

  • Literature review of antibiotic treatment outcomes.
  • Analysis of data from ongoing vaccine clinical trials.

Related Experiment Videos

  • Exploration of emerging research methodologies for chronic symptom management.

    • Main Results:

    • Antibiotics demonstrate high cure rates for acute infections.
    • The vaccine candidate is progressing through clinical evaluation.
    • Chronic symptoms post-infection present a significant challenge requiring further investigation.

    Conclusions:

    • While antibiotics are curative and vaccines preventive, managing chronic symptoms remains a critical unmet need.
    • Further research is essential to develop effective therapeutic strategies for individuals with long-term post-infectious conditions.
    • The focus is shifting towards supportive and restorative care for chronic sequelae.